2002
DOI: 10.2169/internalmedicine.41.403
|View full text |Cite
|
Sign up to set email alerts
|

Long-term Follow-up of Systemic Reactive AA Amyloidosis Secondary to Rheumatoid Arthritis: Successful Treatment with Intermediate-dose Corticosteroid.

Abstract: Reactive AAamyloidosis frequently develops in patients with a long history of rheumatoid arthritis (RA), usually resulting in an unfavorable outcomedue to dysfunction of the vital organs. Wereport a 56-year-old womanwith this form of amyloidosis secondary to RAwhohas been successfully treated with intermediate-dose prednisolone for two and a half years since diagnosis. Because prednisolone is superior to other drugs used for amyloidosis with respect to possible harmful effects on vital organs, we can safely tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0
2

Year Published

2002
2002
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 14 publications
0
8
0
2
Order By: Relevance
“…Generally, AMY is more likely to be a complication of long‐term persisting chronic inflammatory diseases, such as chronic infection and collagen diseases. Among patients with rheumatoid arthritis (a disease commonly complicated by AMY), the risk for AMY is considered to be higher in patients with highly active rheumatoid arthritis 17–19 . In terms of the relationship between CD duration and the risk for AMY, some investigators have reported no association, 7,10 whereas others have found a strong association 2 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Generally, AMY is more likely to be a complication of long‐term persisting chronic inflammatory diseases, such as chronic infection and collagen diseases. Among patients with rheumatoid arthritis (a disease commonly complicated by AMY), the risk for AMY is considered to be higher in patients with highly active rheumatoid arthritis 17–19 . In terms of the relationship between CD duration and the risk for AMY, some investigators have reported no association, 7,10 whereas others have found a strong association 2 .…”
Section: Discussionmentioning
confidence: 99%
“…Among patients with rheumatoid arthritis (a disease commonly complicated by AMY), the risk for AMY is considered to be higher in patients with highly active rheumatoid arthritis. [17][18][19] In terms of the relationship between CD duration and the risk for AMY, some investigators have reported no association, 7,10 whereas others have found a strong association. 2 Thus, there is no consensus on this relationship.…”
Section: Discussionmentioning
confidence: 99%
“…The therapeutic options for renal amyloidosis have been discussed in many studies (5)(6)(7)(8)(9)(10)(11)(12)(13) …”
Section: Introductionmentioning
confidence: 99%
“…Corticosteroids are capable of reducing the magnitude of the acute phase reaction including the synthesis of CRP and SAA. It seems reasonable to treat patients with AA amyloidosis secondary to RA using cytostatic drugs either alone or in combination with prednisolone [8,14,[103][104][105][106]. Although corticosteroid therapy suppressess both CRP and SAA levels in longitudinal studies of patients with RA, the effect is somewhat more pronounced for CRP than for SAA [102].…”
Section: Corticosteroidsmentioning
confidence: 99%